{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,14]],"date-time":"2026-11-14T07:55:13Z","timestamp":1794642913423,"version":"4.9.1"},"reference-count":34,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2014,3,7]],"date-time":"2014-03-07T00:00:00Z","timestamp":1394150400000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["BMC Public Health"],"published-print":{"date-parts":[[2014,12]]},"DOI":"10.1186\/1471-2458-14-236","type":"journal-article","created":{"date-parts":[[2014,3,7]],"date-time":"2014-03-07T10:03:51Z","timestamp":1394186631000},"source":"Crossref","is-referenced-by-count":45,"title":["The lipid profile of HIV-infected patients receiving antiretroviral therapy in a rural Cameroonian population"],"prefix":"10.1186","volume":"14","author":[{"given":"Cavin Epie","family":"Bekolo","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Modestine Becker","family":"Nguena","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Leonard","family":"Ewane","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Patrick Sylvestre","family":"Bekoule","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Basile","family":"Kollo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2014,3,7]]},"reference":[{"key":"6419_CR1","volume-title":"Global Report: UNAIDS Report on the Global AIDS Epidemic 2013","author":"Joint United Nations Programme on HIV\/AIDS (UNAIDS)","year":"2013","unstructured":"Joint United Nations Programme on HIV\/AIDS (UNAIDS): Global Report: UNAIDS Report on the Global AIDS Epidemic 2013. 2013, Geneva: UNAIDS"},{"key":"6419_CR2","doi-asserted-by":"publisher","first-page":"141","DOI":"10.3810\/pgm.2000.04.986","volume":"107","author":"GR Cohan","year":"2000","unstructured":"Cohan GR: HIV-associated metabolic and morphologic abnormality syndrome:Welcome therapy may have unwelcome effects. Postgrad Med. 2000, 107: 141-146.","journal-title":"Postgrad Med"},{"key":"6419_CR3","doi-asserted-by":"publisher","first-page":"49","DOI":"10.2174\/1874192401105010049","volume":"5","author":"ER Feeney","year":"2011","unstructured":"Feeney ER, Mallon PW: HIV and HAART-Associated Dyslipidemia. Open Cardiovasc Med J. 2011, 5: 49-63. 10.2174\/1874192401105010049.","journal-title":"Open Cardiovasc Med J"},{"issue":"3","key":"6419_CR4","first-page":"112","volume":"18","author":"C Grunfeld","year":"2010","unstructured":"Grunfeld C: Dyslipidemia and its Treatment in HIV Infection. Top HIV Med. 2010, 18 (3): 112-118.","journal-title":"Top HIV Med"},{"issue":"8","key":"6419_CR5","doi-asserted-by":"publisher","first-page":"1179","DOI":"10.1097\/00002030-200305230-00010","volume":"17","author":"N Friis-Moller","year":"2003","unstructured":"Friis-Moller N, Weber R, Reiss P: Cardiovascular disease risk factors in HIV patients\u2013association with antiretroviral therapy, Results from the DAD study. AIDS. 2003, 17 (8): 1179-1193. 10.1097\/00002030-200305230-00010.","journal-title":"AIDS"},{"key":"6419_CR6","volume-title":"La population du Cameroun en 2010","author":"Central Bureau of the Census and Population Studies","year":"2010","unstructured":"Central Bureau of the Census and Population Studies: La population du Cameroun en 2010. 2010, Yaounde: Central Bureau of the Census and Population Studies"},{"key":"6419_CR7","volume-title":"Enqu\u00eate D\u00e9mographique et de Sant\u00e9 et \u00e0 Indicateurs Multiples EDS-MICS 2011","author":"National Institute of Statistics","year":"2011","unstructured":"National Institute of Statistics: Enqu\u00eate D\u00e9mographique et de Sant\u00e9 et \u00e0 Indicateurs Multiples EDS-MICS 2011. 2011, Yaounde: National Institute of Statistics"},{"key":"6419_CR8","volume-title":"Rapport annuel des activit\u00e9s de lutte contre le VIH et les IST au Cameroun","author":"Ministere de la Sante Publique du Cameroun","year":"2011","unstructured":"Ministere de la Sante Publique du Cameroun: Rapport annuel des activit\u00e9s de lutte contre le VIH et les IST au Cameroun. 2011, Yaounde: Ministere de la Sante Publique du Cameroun"},{"key":"6419_CR9","doi-asserted-by":"publisher","first-page":"19","DOI":"10.1186\/1742-6405-3-19","volume":"3","author":"JL Ngondi","year":"2006","unstructured":"Ngondi JL, Oben J, Forkah DM, Etame LH, Mbanya D: The effect of different combination therapies on oxidative stress markers in HIV infected patients in Cameroon. AIDS Res Ther. 2006, 3: 19-10.1186\/1742-6405-3-19.","journal-title":"AIDS Res Ther"},{"issue":"6","key":"6419_CR10","doi-asserted-by":"publisher","first-page":"e65126","DOI":"10.1371\/journal.pone.0065126","volume":"8","author":"G Teto","year":"2013","unstructured":"Teto G, Kanmogne GD, Torimiro JN, Alemnji G, Nguemaim FN, Takou D, Nanfack A, Asonganyi T: Lipid peroxidation and total cholesterol in HAART-na\u00efve patients infected with circulating recombinant forms of human immunodeficiency virus type-1 in Cameroon. PLoS ONE. 2013, 8 (6): e65126-10.1371\/journal.pone.0065126.","journal-title":"PLoS ONE"},{"key":"6419_CR11","first-page":"10","volume-title":"Lipides et lipoprot\u00e9ines des sujets camerounais VIH positifs naifs aux antir\u00e9troviraux","author":"J Ngogang","year":"2008","unstructured":"Ngogang J, Oumarou A, Mbuagbaw J, Mbanya D: Proceedings of the 6th Congress of Cameroon Cardiac Society. Lipides et lipoprot\u00e9ines des sujets camerounais VIH positifs naifs aux antir\u00e9troviraux. 2008, PAMJ, 10-"},{"issue":"6","key":"6419_CR12","doi-asserted-by":"crossref","first-page":"353","DOI":"10.1111\/j.1468-1293.2009.00784.x","volume":"11","author":"NF Nguemaim","year":"2010","unstructured":"Nguemaim NF, Mbuagbaw J, Nkoa T, Alemnji G, Teto G, Fanhi TC, Asonganyi T, Same-Ekobo A: Serum lipid profile in highly active antiretroviral therapy-na\u00efve HIV-infected patients in Cameroon: a case\u2013control study. HIV Med. 2010, 11 (6): 353-359.","journal-title":"HIV Med"},{"key":"6419_CR13","volume-title":"Antiretroviral Therapy for HIV Infection in Adults and Adolescents. Recommendations for a Public Health Approach","author":"World Health Organisation","year":"2010","unstructured":"World Health Organisation: Antiretroviral Therapy for HIV Infection in Adults and Adolescents. Recommendations for a Public Health Approach. 2010, revision. http:\/\/whqlibdoc.who.int\/publications\/2010\/9789241599764_eng.pdf"},{"key":"6419_CR14","doi-asserted-by":"publisher","first-page":"33","DOI":"10.1186\/1742-6405-8-33","volume":"8","author":"EW Pefura Yone","year":"2011","unstructured":"Pefura Yone EW, Betyoumin AF, Kengne AP, Folefack FJK, Ngogang J: First-line antiretroviral therapy and dyslipidemia in people living with HIV-1 in Cameroon: a cross-sectional study. AIDS Res Ther. 2011, 8: 33-10.1186\/1742-6405-8-33.","journal-title":"AIDS Res Ther"},{"key":"6419_CR15","first-page":"1","volume":"10","author":"CNAA Lissock","year":"2011","unstructured":"Lissock CNAA, Sobngwi E, Ngassam E, Ngoa LSE: Rural and urban differences in metabolic profiles in a Cameroonian population. PAMJ. 2011, 10: 1-","journal-title":"PAMJ"},{"issue":"6","key":"6419_CR16","doi-asserted-by":"crossref","first-page":"499","DOI":"10.1093\/clinchem\/18.6.499","volume":"18","author":"WT Friedewald","year":"1972","unstructured":"Friedewald WT, Levy RI, Fredrickson DS: Estimation of the concentration of low density lipoprotein cholesterol in plasma without use of the preparative ultracentrifuge. Clin Chem. 1972, 18 (6): 499-502.","journal-title":"Clin Chem"},{"key":"6419_CR17","doi-asserted-by":"crossref","unstructured":"Executive summary of the third report of the national cholesterol education program (NCEP) expert panel on detection, evaluation, and treatment of high blood cholesterol in adults (adult treatment panel III). JAMA. 2001, 285 (19): 2486-2497. 10.1001\/jama.285.19.2486.","DOI":"10.1001\/jama.285.19.2486"},{"issue":"1","key":"6419_CR18","doi-asserted-by":"publisher","first-page":"31","DOI":"10.1186\/1742-6405-9-31","volume":"9","author":"A Tadewos","year":"2012","unstructured":"Tadewos A, Addis Z, Ambachew H, Banerjee S: Prevalence of dyslipidemia among HIV-infected patients using first-line highly active antiretroviral therapy in Southern Ethiopia: a cross-sectional comparative group study. AIDS Res Ther. 2012, 9 (1): 31-10.1186\/1742-6405-9-31.","journal-title":"AIDS Res Ther"},{"issue":"2","key":"6419_CR19","doi-asserted-by":"publisher","first-page":"141","DOI":"10.1097\/QAI.0b013e318219a3d1","volume":"57","author":"C Armstrong","year":"2011","unstructured":"Armstrong C, Liu E, Grinspoon S, Okuma J, Spiegelman D, Guerino C, Njelekela M, Fawzi W, Hawkins C: Dyslipidemia in an HIV-positive antiretroviral treatment-naive population in Dar es Salaam Tanzania. J Acquir Immune Defic Syndr. 2011, 57 (2): 141-145. 10.1097\/QAI.0b013e318219a3d1.","journal-title":"J Acquir Immune Defic Syndr"},{"issue":"4","key":"6419_CR20","doi-asserted-by":"publisher","first-page":"447","DOI":"10.2217\/clp.11.25","volume":"6","author":"CD Malvestutto","year":"2011","unstructured":"Malvestutto CD, Aberg JA: Management of dyslipidemia in HIV-infected patients. Clin Lipidol. 2011, 6 (4): 447-462. 10.2217\/clp.11.25.","journal-title":"Clin Lipidol"},{"issue":"6","key":"6419_CR21","doi-asserted-by":"publisher","first-page":"725","DOI":"10.1097\/00002030-200104130-00008","volume":"15","author":"H Pernerstorfer-Schoen","year":"2001","unstructured":"Pernerstorfer-Schoen H, Jilma B, Perschler A, Wichlas S, Schindler K, Schindl A, Rieger A, Wagner OF, Quehenberger P: Sex differences in HAART-associated dyslipidaemia. AID. 2001, 15 (6): 725-734. 10.1097\/00002030-200104130-00008.","journal-title":"AID"},{"issue":"1","key":"6419_CR22","doi-asserted-by":"publisher","first-page":"26","DOI":"10.4103\/2141-9248.109468","volume":"3","author":"C Daniyam","year":"2013","unstructured":"Daniyam C, Iroezindu M: Lipid profile of anti-retroviral treatment-naive HIV-infected patients in Jos Nigeria. Ann Med Health Sci Res. 2013, 3 (1): 26-30. 10.4103\/2141-9248.109468.","journal-title":"Ann Med Health Sci Res"},{"issue":"1","key":"6419_CR23","doi-asserted-by":"publisher","first-page":"17","DOI":"10.1007\/s10156-011-0275-5","volume":"18","author":"F Oka","year":"2012","unstructured":"Oka F, Naito T, Oike M, Imai R, Saita M, Inui A, Mitsuhashi K, Isonuma H, Shimbo T: Correlation between HIV disease and lipid metabolism in antiretroviral-naive HIV-infected patients in Japan. J Infect Chemother. 2012, 18 (1): 17-21. 10.1007\/s10156-011-0275-5.","journal-title":"J Infect Chemother"},{"key":"6419_CR24","doi-asserted-by":"publisher","first-page":"50","DOI":"10.1186\/1476-511X-12-50","volume":"12","author":"JN Kiage","year":"2013","unstructured":"Kiage JN, Heimburger DC, Nyirenda CK, Wellons MF, Bagchi S, Chi BH, Koethe JR, Arnett DK, Kabagambe EK: Cardiometabolic risk factors among HIV patients on antiretroviral therapy. Lipids Health Dis. 2013, 12: 50-10.1186\/1476-511X-12-50.","journal-title":"Lipids Health Dis"},{"issue":"22","key":"6419_CR25","doi-asserted-by":"publisher","first-page":"2978","DOI":"10.1001\/jama.289.22.2978","volume":"289","author":"SA Riddler","year":"2003","unstructured":"Riddler SA, Smit E, Cole SR, Li R, Chmiel JS, Dobs A, Palella F, Visscher B, Evans R, Kingsle LA: Impact of HIV infection and HAART on serum lipids in men. JAMA. 2003, 289 (22): 2978-2982. 10.1001\/jama.289.22.2978.","journal-title":"JAMA"},{"key":"6419_CR26","volume-title":"Directives nationales de prise en charge par les antir\u00e9troviraux des personnes (Adultes et Adolescents) infect\u00e9es par le VIH","author":"Ministere de la Sante Publique du Cameroun","year":"2010","unstructured":"Ministere de la Sante Publique du Cameroun: Directives nationales de prise en charge par les antir\u00e9troviraux des personnes (Adultes et Adolescents) infect\u00e9es par le VIH. 2010, Yaounde: Ministere de la Sante Publique du Cameroun"},{"issue":"2","key":"6419_CR27","doi-asserted-by":"publisher","first-page":"85","DOI":"10.1111\/j.1468-1293.2006.00346.x","volume":"7","author":"PN Kumar","year":"2006","unstructured":"Kumar PN, Rodriguez-French A, Thompson MA, Tashima KT, Averitt D, Wannamaker PG, Williams VC, Shaefer MS, Pakes GE, Pappa KA: A prospective, 96-week study of the impact of Trizivir, Combivir\/nelfinavir, and lamivudine\/stavudine\/nelfinavir on lipids, metabolic parameters and efficacy in antiretroviral-naive patients: effect of sex and ethnicity. HIV Med. 2006, 7 (2): 85-98. 10.1111\/j.1468-1293.2006.00346.x.","journal-title":"HIV Med"},{"key":"6419_CR28","doi-asserted-by":"publisher","first-page":"1601","DOI":"10.1097\/00002030-200007280-00016","volume":"14","author":"JJ Eron Jr","year":"2000","unstructured":"Eron JJ, Murphy RL, Peterson D: A comparison of stavudine, didanosine and indinavir with zidovudine, lamivudine and indinavir for the initial treatment of HIV-1 infected individuals: selection of thymidine analog regimen therapy (START II). AIDS. 2000, 14: 1601-1610. 10.1097\/00002030-200007280-00016.","journal-title":"AIDS"},{"issue":"2","key":"6419_CR29","doi-asserted-by":"publisher","first-page":"191","DOI":"10.1001\/jama.292.2.191","volume":"292","author":"JE Gallant","year":"2004","unstructured":"Gallant JE, Staszewski S, Pozniak AL, De Jesus E, Suleiman JM, Miller MD, Coakley DF, Lu B, Toole JJ, Cheng AK: Efficacy and safety of tenofovir DF vs stavudine in combination therapy in antiretroviral-naive patients: a 3-year randomized trial. JAMA. 2004, 292 (2): 191-201. 10.1001\/jama.292.2.191.","journal-title":"JAMA"},{"issue":"1","key":"6419_CR30","doi-asserted-by":"publisher","first-page":"e19","DOI":"10.1371\/journal.pmed.0010019","volume":"1","author":"F van Leth","year":"2004","unstructured":"van Leth F, Phanuphak P, Stroes E, Gazzard B, Cahn P, Raffi F, Wood R, Bloch M, Katlama C, Kastelein JJ, Schechter M, Murphy RL, Horban A, Hall DB, Lange JM, Reiss P: Nevirapine and efavirenz elicit different changes in lipid profiles in antiretroviral-therapy-naive patients infected with HIV-1. PLoS Med. 2004, 1 (1): e19-10.1371\/journal.pmed.0010019.","journal-title":"PLoS Med"},{"issue":"6676","key":"6419_CR31","doi-asserted-by":"publisher","first-page":"784","DOI":"10.1136\/bmj.298.6676.784","volume":"298","author":"WY Craig","year":"1989","unstructured":"Craig WY, Palomaki GE, Haddow JE: Cigarette smoking and serum lipid and lipoprotein concentrations: an analysis of published data. BMJ. 1989, 298 (6676): 784-788. 10.1136\/bmj.298.6676.784.","journal-title":"BMJ"},{"issue":"7","key":"6419_CR32","doi-asserted-by":"publisher","first-page":"2506","DOI":"10.1210\/jc.2006-2190","volume":"92","author":"VA Triant","year":"2007","unstructured":"Triant VA, Lee H, Hadigan C, Grinspoon SK: Increased acute myocardial infarction rates and cardiovascular risk factors among patients with human immunodeficiency virus disease. J Clin Endocrinol Metab. 2007, 92 (7): 2506-2512. 10.1210\/jc.2006-2190.","journal-title":"J Clin Endocrinol Metab"},{"key":"6419_CR33","first-page":"751827","volume":"2012","author":"MG Neuman","year":"2012","unstructured":"Neuman MG, Schneider M, Nanau RM, Parry C: Alcohol consumption, progression of disease and other comorbidities, and responses to antiretroviral medication in people living with HIV. AIDS Res Treat. 2012, 2012: 751827-","journal-title":"AIDS Res Treat"},{"issue":"4","key":"6419_CR34","doi-asserted-by":"publisher","first-page":"359","DOI":"10.5603\/KP.2013.0063","volume":"71","author":"A Waskiewicz","year":"2013","unstructured":"Waskiewicz A, Sygnowska E: Alcohol intake and cardiovascular risk factor profile in men participating in the WOBASZ study. Kardiol Pol. 2013, 71 (4): 359-365. 10.5603\/KP.2013.0063.","journal-title":"Kardiol Pol"}],"container-title":["BMC Public Health"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/1471-2458-14-236.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1186\/1471-2458-14-236\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/1471-2458-14-236","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,5,24]],"date-time":"2024-05-24T21:35:42Z","timestamp":1716586542000},"score":1,"resource":{"primary":{"URL":"http:\/\/bmcpublichealth.biomedcentral.com\/articles\/10.1186\/1471-2458-14-236"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2014,3,7]]},"references-count":34,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2014,12]]}},"alternative-id":["6419"],"URL":"https:\/\/doi.org\/10.1186\/1471-2458-14-236","relation":{},"ISSN":["1471-2458"],"issn-type":[{"value":"1471-2458","type":"electronic"}],"subject":[],"published":{"date-parts":[[2014,3,7]]},"article-number":"236"}}